Co-Authors
This is a "connection" page, showing publications co-authored by Andrew Hayward and Laura Shallcross.
Connection Strength
1.528
-
COVID-19 infection and attributable mortality in UK care homes: cohort study using active surveillance and electronic records (March-June 2020). Age Ageing. 2021 06 28; 50(4):1019-1028.
Score: 0.238
-
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study. Lancet Infect Dis. 2021 11; 21(11):1529-1538.
Score: 0.238
-
Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study. Lancet Healthy Longev. 2021 Jun; 2(6):e362-e370.
Score: 0.237
-
Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England. N Engl J Med. 2021 04 29; 384(17):1671-1673.
Score: 0.234
-
Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey. Lancet Healthy Longev. 2021 Mar; 2(3):e129-e142.
Score: 0.232
-
Study Protocol: Understanding SARS-Cov-2 infection, immunity and its duration in care home residents and staff in England (VIVALDI). Wellcome Open Res. 2020; 5:232.
Score: 0.232
-
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study. Lancet Healthy Longev. 2021 Sep; 2(9):e544-e553.
Score: 0.060
-
Impact of baseline cases of cough and fever on UK COVID-19 diagnostic testing rates: estimates from the Bug Watch community cohort study. Wellcome Open Res. 2020; 5:225.
Score: 0.057